欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0483/002
药品名称
Novastan Multidos
活性成分
Argatroban 100.0 mg/g
剂型
Concentrate for solution for infusion
上市许可持有人
Mitsubishi Tanabe Pharma GmbH, Germany
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
France (FR)
Germany (DE)
Netherlands (NL)
Austria (AT)
Argatra Multidose 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung
Italy (IT)
Finland (FI)
Novastan Multidos
许可日期
2010/05/26
最近更新日期
2025/02/03
药物ATC编码
B01AE03 argatroban
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0483_002_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0483_002_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_0483_002_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_0483_002_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase